Press Releases

Press Releases

    Date Title View
    12/24/14
    Summary ToggleHorizon Pharma plc Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. for Filing an ANDA Against PENNSAID(R) 2%
    11/24/14
    Summary ToggleHorizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference
    11/18/14
    Summary ToggleHorizon Pharma plc Announces Presentation of Data Showing Unmet Need in Rheumatoid Arthritis and the Positive Effect of RAYOS(R) (Prednisone) Delayed-Release Tablets in Reducing Joint Stiffness of RA Throughout the Day
    11/14/14
    Summary ToggleHorizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling Shareholders
    11/13/14
    Summary ToggleHorizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders
    11/12/14
    Summary ToggleHorizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting
    11/12/14
    Summary ToggleHorizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Tablets Patent Infringement Litigation
    11/11/14
    Summary ToggleHorizon Pharma plc to Present at the Stifel 2014 Healthcare Conference
    11/06/14
    Summary ToggleHorizon Pharma plc Reports Third Quarter 2014 Financial Results and Raises Guidance for 2014 and 2015
    11/06/14
    Summary ToggleHorizon Pharma plc Appoints John J. Kody as Executive Vice President and Chief Commercial Officer
    Displaying 1 - 10 of 57 results